Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Retained Earnings (2018 - 2026)

Alector's (ALEC) quarterly Retained Earnings came in at -$1.0 billion in Q2 2026, down 204.82% year-over-year from $971.2 million in Q2 2025, and down 201.24% quarter-over-quarter from $1.0 billion in Q1 2026.

Analysis

Alector (ALEC) Retained Earnings (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Retained Earnings for 9 consecutive years, with -$1.0 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Retained Earnings fell 204.82% year-over-year to -$1.0 billion in Q2 2026; TTM through Jun 2026 was -$1.0 billion, a 204.82% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 4.9% from the prior year.
  • Retained Earnings was -$1.0 billion for Q2 2026 at Alector, down from $1.0 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at $1.0 billion in Q1 2026 and troughed at -$1.0 billion in Q2 2026.
  • A 5-year average of $784.0 million and a median of $884.8 million in 2023 frame the typical range for Retained Earnings.
  • Across the five-year window, Retained Earnings increased 14.15% in 2024 and tumbled 204.82% in 2026, its largest moves.
  • Over 5 years, Retained Earnings stood at $798.7 million in 2022, then grew by 5.68% to $844.0 million in 2023, then rose by 13.22% to $955.7 million in 2024, then advanced by 4.9% to $1.0 billion in 2025, then plunged by 201.54% to -$1.0 billion in 2026.
  • The last three Retained Earnings figures came in at -$1.0 billion (Q2 2026), $1.0 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 Alector 274.68 Mn 101.88 Mn - -1.02 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.02 Bn
Mar 31, 2026 1.01 Bn
Dec 31, 2025 1.00 Bn
Sep 30, 2025 992.29 Mn
Jun 30, 2025 971.19 Mn
Mar 31, 2025 964.01 Mn
Dec 31, 2024 955.66 Mn
Sep 30, 2024 945.05 Mn
Jun 30, 2024 936.01 Mn
Mar 31, 2024 925.46 Mn
Dec 31, 2023 844.04 Mn
Sep 30, 2023 831.91 Mn
Jun 30, 2023 821.85 Mn
Mar 31, 2023 810.75 Mn
Dec 31, 2022 798.70 Mn
Sep 30, 2022 787.10 Mn
Jun 30, 2022 775.84 Mn
Mar 31, 2022 762.46 Mn
Dec 31, 2021 748.04 Mn
Sep 30, 2021 726.69 Mn